Jorgen B Lassen

Title: Jorgen B Lassen: Innovator in Pain Treatment

Introduction

Jorgen B Lassen is a notable inventor based in Glostrup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pain. With a total of three patents to his name, Lassen's work has the potential to impact both human and veterinary medicine.

Latest Patents

Lassen's latest patents include innovative methods for pain management. One of his key inventions is a method for treating pain in human or non-human animals, which involves administering an effective, non-toxic amount of paroxetine or a pharmaceutically acceptable salt thereof. Another significant patent is for the compound (-)-trans-4-(4-fluorophenyl)-3-[(4-methoxyphenoxy)methyl]-1-methylpiperidine and its pharmaceutically-acceptable acid addition salts. This compound is designed to alleviate various physiological abnormalities by potentiating the 5-hydroxytryptamine (5-HT) levels in subjects in need.

Career Highlights

Jorgen B Lassen is currently associated with A/S Ferrosan, a company known for its focus on healthcare and pharmaceuticals. His work at Ferrosan has allowed him to develop and refine his innovative approaches to pain treatment.

Collaborations

Lassen has collaborated with notable colleagues in his field, including Jorgen A Christensen and Erling N Petersen. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jorgen B Lassen is a prominent figure in the pharmaceutical industry, with a focus on innovative pain treatment solutions. His contributions through patents and collaborations highlight his commitment to improving healthcare outcomes.